In the News

413 News Items found
Mamadou Diallo
Learn about diversity and inclusion at Memorial Sloan Kettering, as people from across MSK share their insights and personal experiences.
Richard Nixon with Benno and Nancy Schmidt
In 1971, Richard Nixon launched a “war on cancer.” It’s still raging.
An illustration of CRISPR-Cas9
In the Lab
A freely accessible software program provides researchers with an easy way to optimize a popular genome-editing tool.
MSK medical oncologist Luis Diaz, Jr.
In the Clinic
A new paper from MSK physician-scientist Luis Diaz presents the evidence on which the FDA approved the immunotherapy drug pembrolizumab for cancers with a specific genetic abnormality.
Human metastatic melanoma cells in a lymph node. ENPP1, a protein involved in immune evasion, is shown in green.
The research identifies a protein called ENPP1 as a potential drug target in the treatment of advanced cancers with chromosome instability.
Mushrooms growing on a mossy log on the forest floor
Dr. Gary Deng of the Integrative Medicine Service helps separate the hype from the proven health benefits of mushroom supplements.
Jimmie Holland in early 1990s
In Memoriam
Dr. Holland was a tireless advocate for supporting the emotional and psychological needs of people with cancer. She also made huge strides in reducing the stigma surrounding the disease.
A hand points to brain images on a screen.
In the Clinic
MSK doctors and scientists are leading the charge to find new and innovative ways to treat metastatic brain cancer.
Male scientist wearing protective gear working with radiopharmaceutical materials.
Article
Thanks to pioneering work done at MSK, a powerful new form of radiation therapy is changing the treatment of advanced cancers.
Jedd Wolchok in his lab
In the Lab
During the COVID-19 pandemic, MSK doctors and researchers are applying their knowledge about immunology toward the development of treatments.